DK0609280T3 - Humane IL-3 varianter - Google Patents

Humane IL-3 varianter

Info

Publication number
DK0609280T3
DK0609280T3 DK92921235T DK92921235T DK0609280T3 DK 0609280 T3 DK0609280 T3 DK 0609280T3 DK 92921235 T DK92921235 T DK 92921235T DK 92921235 T DK92921235 T DK 92921235T DK 0609280 T3 DK0609280 T3 DK 0609280T3
Authority
DK
Denmark
Prior art keywords
pct
variants
human
sec
methods
Prior art date
Application number
DK92921235T
Other languages
English (en)
Inventor
Mathew Alexander Vadas
Angel Francisco Lopez
Mary Frances Shannon
Original Assignee
Medvet Science Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medvet Science Pty Ltd filed Critical Medvet Science Pty Ltd
Application granted granted Critical
Publication of DK0609280T3 publication Critical patent/DK0609280T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5403—IL-3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK92921235T 1991-10-07 1992-10-07 Humane IL-3 varianter DK0609280T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPK874291 1991-10-07
PCT/AU1992/000535 WO1993007171A1 (en) 1991-10-07 1992-10-07 Human il-3 variants

Publications (1)

Publication Number Publication Date
DK0609280T3 true DK0609280T3 (da) 1999-10-25

Family

ID=3775735

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92921235T DK0609280T3 (da) 1991-10-07 1992-10-07 Humane IL-3 varianter

Country Status (11)

Country Link
US (1) US5591427A (da)
EP (1) EP0609280B1 (da)
JP (1) JPH07501520A (da)
AT (1) ATE179211T1 (da)
AU (1) AU668364B2 (da)
CA (1) CA2120707A1 (da)
DE (1) DE69228997T2 (da)
DK (1) DK0609280T3 (da)
ES (1) ES2133329T3 (da)
GR (1) GR3030032T3 (da)
WO (1) WO1993007171A1 (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6586222B1 (en) 1989-08-16 2003-07-01 Chiron Corporation Recombinant PR-3 and compositions thereof
US5843693A (en) * 1989-08-16 1998-12-01 Chiron Corporation Assay method for screening for inhibitors of proTNF conversion
US5998378A (en) * 1989-08-16 1999-12-07 Chiron Corporation Compositions for the inhibition of TNF hormone formation and uses thereof
US6413509B1 (en) 1992-11-24 2002-07-02 S. Christopher Bauer Methods of ex-vivo expansion of hematopoietic cells using interleukin-3 mutant polypeptides with other hematopoietic growth factors
US6361976B1 (en) 1992-11-24 2002-03-26 S. Christopher Bauer Co-administration of interleukin-3 mutant polypeptides with CSF'S for multi-lineage hematopoietic cell production
US5772992A (en) * 1992-11-24 1998-06-30 G.D. Searle & Co. Compositions for co-administration of interleukin-3 mutants and other cytokines and hematopoietic factors
US6153183A (en) * 1992-11-24 2000-11-28 G. D. Searle & Company Co-administration of interleukin-3 mutant polypeptides with CSF's or cytokines for multi-lineage hematopoietic cell production
US6361977B1 (en) * 1992-11-24 2002-03-26 S. Christopher Bauer Methods of using multivariant IL-3 hematopoiesis fusion protein
US7091319B1 (en) * 1992-11-24 2006-08-15 Bauer S Christopher IL-3 variant hematopoiesis fusion protein
ATE238421T1 (de) * 1992-11-24 2003-05-15 Searle & Co Interleukin-3 (il-3)-polypeptide mith mehreren mutationen
US6436387B1 (en) * 1992-11-24 2002-08-20 G.D. Searle & Co. Methods of ex-vivo expansion of hematopoietic cells using multivariant IL-3 hematopoiesis chimera proteins
US6403076B1 (en) 1992-11-24 2002-06-11 S. Christopher Bauer Compositions for increasing hematopoiesis with interleukin-3 mutants
US6057133A (en) * 1992-11-24 2000-05-02 G. D. Searle Multivariant human IL-3 fusion proteins and their recombinant production
US5738849A (en) * 1992-11-24 1998-04-14 G. D. Searle & Co. Interleukin-3 (IL-3) variant fusion proteins, their recombinant production, and therapeutic compositions comprising them
US5939063A (en) * 1993-07-28 1999-08-17 Medvet Science Pty. Ltd. Modified forms of granulocyte macrophage-colony stimulating factor as antagonists
CA2176115A1 (en) * 1993-11-10 1995-05-18 Clifford M. Snapper Compositions and method for stimulating antibody release by b lymphocytes
US20050059149A1 (en) * 1993-11-22 2005-03-17 Bauer S. Christopher Methods of ex-vivo expansion of hematopoeitic cells using multivariant IL-3 hematopoiesis chimera proteins
EP0749494A1 (en) 1994-03-07 1996-12-27 Chiron Corporation Compositions for the inhibition of tnf formation and uses thereof
US6465616B1 (en) 1994-04-08 2002-10-15 Bresagen Limited Interleukin-5 antagonist
US6017523A (en) * 1995-06-06 2000-01-25 G.D. Searle & Co. Therapeutic methods employing mutant human interleukin-3 (IL-3) polypeptides
AU703627B2 (en) * 1995-10-05 1999-03-25 G.D. Searle & Co. Interleuken-3 (IL-3) receptor agonists

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
OA09736A (en) * 1987-02-18 1993-11-30 Schering Biotech Corp "Human interleukin-3 and muteins thereof".
EP0413383B1 (en) * 1989-08-14 1997-06-18 Gist-Brocades N.V. Mutants of human interleukin-3

Also Published As

Publication number Publication date
ATE179211T1 (de) 1999-05-15
JPH07501520A (ja) 1995-02-16
EP0609280B1 (en) 1999-04-21
AU2753892A (en) 1993-05-03
CA2120707A1 (en) 1993-04-15
EP0609280A1 (en) 1994-08-10
AU668364B2 (en) 1996-05-02
EP0609280A4 (en) 1994-09-14
WO1993007171A1 (en) 1993-04-15
ES2133329T3 (es) 1999-09-16
DE69228997T2 (de) 1999-08-26
GR3030032T3 (en) 1999-07-30
US5591427A (en) 1997-01-07
DE69228997D1 (de) 1999-05-27

Similar Documents

Publication Publication Date Title
DK0609280T3 (da) Humane IL-3 varianter
DE69830404D1 (de) P38-inhibitoren
BR9714415A (pt) Heterociclos contendo nitrogênio substituìdo como inibidores de proteìnas quinase p38
GEP20032954B (en) Heterocyclic Inhibitors of P38
MY117696A (en) INHIBITORS OF p38
ATE184776T1 (de) Biokompatibles implantat für die zeitliche abstimmung der ovulation von stuten
ATE393831T1 (de) Zusammensetzung zur in vivo erzeugung von therapeutischen produkten
ATE218879T1 (de) Therapeutische verwendungen von bakterizide/permeabilitätserhöhende protein dimer produkte
MX9801596A (es) Composiciones aliviadoras del prurito, cosmeticas y farmaceuticas o ambas.
DE69526937D1 (de) Verwendung von methanbisphosphonsäurederivaten zur behandlung von aufgelockerten prothesen
NO941681L (no) Humane IL-4 mutant proteiner
ATE154235T1 (de) Kosmetische oder pharmazeutische zusammensetzungen zur topischen anwendung die deacylierten glycerophospholipide enthalten
ATE382061T1 (de) Mittel zur induktion von apoptosis und zur therapieanwendung
DE69711078D1 (de) Topische verwendung von kappa-opioidrezeptoragonisten zur behandlung von augenschmerz
TR200100637T2 (tr) Yeni doğal ürün türevleri
DE69704213D1 (de) Bioaromatische dibenzofuranderivate und verwendung in der human- oder tiermedizin und in der kosmetik
ID23184A (id) Garam-garam peptida bpc dengan aktivitas organoprotektif proses pembuatan dan penggunaannya dalam terapi
DE69816808D1 (de) Somatostatin agoniste zur reduzierung von körpergewicht
DE69323191D1 (de) Wasserlösliche retinoide
ATE132877T1 (de) Emulgatorfreie emulsionspolymere in pharmazeutischen zubereitungen mit verzögerter wirkstofffreigabe und ihre herstellung
ATE175349T1 (de) Verwendung von etofibrat und pharmazeutische zusammensetzungen, enthaltend etofibrat, zur behandlung der diabetischen angio- und retinopathie
MY129421A (en) INHIBITORS OF p38